Showing results (181-190 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|April 6, 2026
Identification of small molecules that enhance aminoglycoside-mediated suppression of CFTR and NF1 nonsense mutationsJoshua Sammons, Jianguo Chen, Kari Thrasher, et al.
Molecular Therapy. Oncology|May 8, 2026
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomasKonstantinos Vazaios, Antonio C Tallon-Cobos, Louisa P J van Oosterhout, et al.
Molecular Therapy. Oncology|August 15, 2026
ICAM1-targeted costimulation extends HER2 CAR T cytotoxicity to HER2-low and HER2-negative tumors through synergy with TCR signalingYogindra Vedvyas, Yanping Yang, Aroshi Mitra, et al.
Molecular Therapy. Oncology|August 16, 2026
Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decisionArthur Leclerc, Evelyne Emery, Guénaëlle Levallet
Molecular Therapy. Oncology|August 22, 2026
Engineered indoleamine 2,3-dioxygenase variant: Oxidative activation of prodrug indole-3-acetic acid against cancer cells for targeted therapyLiru Liu, Wanfang Li, Sheng Ye
Molecular Therapy. Oncology|August 28, 2026
IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targetingLaura Gehrcken, Jasper Ott, Astrid Van den Eynde, et al.
Molecular Therapy. Oncology|August 28, 2026
Prevention of HNSCC by chewing gum delivery of enzymes/antimicrobials to reduce carcinogenic acetaldehyde produced by pathogenic microbesGeetanjali Wakade, Serena Chaolu Liu, Nhi Eliana Diep, et al.
Molecular Therapy. Oncology|August 28, 2026
CAR design equips diverse immune cells with unique antigen-specific activation identitiesAyano Sugiyama-Finnis, Takaharu Kimura, Kiyoko Izawa, et al.
Molecular Therapy. Oncology|August 30, 2026
Additive effect of Ruta graveolens bioactive phytoconstituents and cisplatin through PKC/MEK/ERK pathway in glioblastomaGrazia Romano, Valentina Morgera, Antonio Pezone, et al.
Molecular Therapy. Oncology|September 18, 2026
Erratum: AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancerTatsuki Ikoma, Keigo Araki, Mai Kitagawa, et al.
Pageof 41